ENTITY
SciClone Pharmaceuticals

SciClone Pharmaceuticals (SCICLONE HK)

108
Analysis
Health Care • China
SciClone Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing pharmaceutical products for oncology and severe infection in Mainland China and internationally. Its portfolio includes proprietary product Zadaxin, used for hepatitis B, hepatitis C, and certain cancers, as well as in-licensed products like Zometa, DANYELZA, and Angiomax. The company was founded in 1990 and is headquartered in Shanghai, China.
more
bullish•Infocom Corp
•22 Jun 2024 15:00

(Mostly) Asia-Pac M&A: Infocom, Capitol Health, MMA Offshore, Mimasu, Tatsuta Elect., Great Eastern

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
783 Views
Share
bullish•Fancl Corp
•17 Jun 2024 00:28

Merger Arb Mondays (17 Jun) - Fancl, Tatsuta, A8, China TCM, GAPack, CPMC, Malaysia Airports, Bapcor

This week, the highest gross spreads are HEC Pharma (127.1%), Hollysys (26.1%), Fancl (17.8%), Asia Cement China (13.4%), Ansarada (11.1%),...

Logo
538 Views
Share
bullish•A8 New Media
•13 Jun 2024 09:33

A8 Media (800 HK): A 163% Premium to Undisturbed? Yes Please.

Pricing looks full. This is a one trick pony illiquid stock. No competing Offer will emerge. Assuming mid-October payment, I'd be paying up to...

Logo
515 Views
Share
•12 Jun 2024 08:55

Sciclone Pharmaceuticals (6600.HK) Privatization Update - Some "Unstable Factors" During Voting

​Shareholders may vote against privatization due to dissatisfaction with Offer Price, risking a potential plunge if privatization fails.Current...

Logo
627 Views
Share
•10 Jun 2024 00:32

Merger Arb Mondays (10 Jun) - GA Pack, Asia Cement, CPMC, Nagatanien, APM, Ansarada, Genex, Hollysys

This week, the highest gross spreads are HEC Pharma (121.3%), Hollysys (18.9%), Ansarada (11.6%), Asia Cement China (11.1%), GA Pack (10.4%),...

Logo
757 Views
Share
x